News about Drug Discovery & Development

Lupin and Huons to Commercialize Cyclosporine Ophthalmic Nanoemulsion in Mexico

Lupin has signed a license and supply deal with Huons Co. Ltd. for the registration and marketing of Cyclosporine Ophthalmic Nanoemulsion, a 0.4mL Single-use Vial, in Mexico.

Drug Discovery & Development | 24/07/2024 | By Aishwarya |  626

Rona Therapeutics Secures USD 35 Million in Series A+ Financing

Rona Therapeutics has received USD 35 million in Series A+ financing round.

Drug Discovery & Development | 22/07/2024 | By Aishwarya |  628

Glenmark Gets ANDA Approval for Topiramate Capsules

Glenmark Pharmaceuticals Ltd. has been granted final approval by the United States Food and Drug Administration (US FDA) for Topiramate Capsules USP, 15 mg and 25 mg.

Drug Discovery & Development | 22/07/2024 | By Aishwarya |  672

Mankind Pharma Signs License Deal with Takeda to Commercialise Acidity Drug in India

Mankind Pharma has signed a non-exclusive patent licence agreement with Takeda Pharmaceuticals for commercialising acidity drug Vonoprazan in the Indian market.

Drug Discovery & Development | 22/07/2024 | By Aishwarya |  1179

Lupin Gets Tentative Approval from US FDA for RLD Sutab

Lupin has secured tentative approval from US FDA for its Abbreviated New Drug Application for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets, 1.479 g/0.225 g/0.188 g, to market a generic equivalent of Sutab Tablets, 1.479 g/0.225 g/0.188 g, of Braintree Laboratories Inc.

Drug Discovery & Development | 18/07/2024 | By Aishwarya |  649

Nona Biosciences Signs Partnership Deal with Alaya.bio to Advance CAR-T Cell Therapy

Nona Biosciences has entered into a collaboration agreement with Alaya. bio to precisely target and reprogram cells in situ and thus to significantly simplify the way CAR-T cell therapies in particular are being developed, manufactured and administered.

Drug Discovery & Development | 15/07/2024 | By Aishwarya |  653

Dr. Reddy's Laboratories Launches Muslaxin in Russia

Dr. Reddy's Russia arm, part of the global pharmaceutical company Dr. Reddy’s Laboratories, has introduced Muslaxin (INN Ibuprofen 400 mg + Chlorzoxazone 500 mg), the first combination drug of NSAID and muscle relaxant that does not have generics in the Russian Federation.

Drug Discovery & Development | 12/07/2024 | By Aishwarya |  2135

Nusano and PharmaLogic to Offer Current and Emerging Radiopharmaceuticals

Nusano Inc. has inked a supply agreement with PharmaLogic to provide a more efficient and reliable supply of critical radioisotopes.

Drug Discovery & Development | 11/07/2024 | By Aishwarya |  258

Alembic Pharma Gets USFDA Approval for Bromfenac Ophthalmic Solution

Alembic Pharmaceuticals has secured final approval from the US Food and Drug Administration (USFDA) for its generic Bromfenac Ophthalmic Solution.

Drug Discovery & Development | 11/07/2024 | By Aishwarya |  1042

Lupin Gets Tentative Approval from US FDA for Empagliflozin, Linagliptin and Metformin Hydrochloride

Lupin has secured tentative approval from the United States Food and Drug Administration (US FDA)for its Abbreviated New Drug Application for Empagliflozin, Linagliptin and Metformin Hydrochloride Extended-Release (ER) Tablets.

Drug Discovery & Development | 10/07/2024 | By Aishwarya |  867